
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
IQGAP3 CRISPR/Cas9 KO Plasmid (h) | sc-406335 | 20 µg | $397.00 |
IQGAP3 (IQ motif containing GTPase activating protein 3) is a scaffolding protein that coordinates signaling and cytoskeletal dynamics by coupling small GTPases, actin regulatory factors, and kinase cascades. It contributes to cell-cycle progression, directional migration, and adhesion remodeling, integrating inputs from pathways such as MAPK/ERK and Rho-family GTPase signaling to shape proliferative and motility programs. Dysregulated IQGAP3 expression has been reported in multiple tumor contexts and is frequently studied for its association with enhanced proliferation, invasiveness, and altered epithelial–mesenchymal features. As a human gene, IQGAP3 is widely used as a node for dissecting network-level control of cytoskeletal organization and mitogenic signaling in mechanistic disease models.
IQGAP3 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the IQGAP3 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the IQGAP3 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the IQGAP3 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish IQGAP3 protein expression.
This CRISPR knockout system enables efficient generation of IQGAP3-deficient cell models for investigation of IQGAP3 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.